Jin Medical International (ZJYL) Cash & Current Investments (2022 - 2025)

Jin Medical International's Cash & Current Investments history runs 4 years deep, the most recent figure standing at $29.6 million for Q3 2025.

• In Q3 2025, Cash & Current Investments rose 59.12% year-over-year to $29.6 million; the TTM figure through Sep 2025 stood at $29.6 million (changed N/A YoY), while the FY2025 annual figure was $29.6 million, up 59.12% from the prior year.
• Cash & Current Investments came in at $29.6 million for Q3 2025 at Jin Medical International, up from $28.0 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $29.6 million in Q3 2025 to a low of $2.3 million in Q3 2022.
• A 4-year average of $17.4 million and a median of $18.6 million in 2024 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments surged 329.18% in 2023 and increased 16.3% in 2025, its largest moves.
• Jin Medical International's Cash & Current Investments stood at $2.3 million in 2022, then soared by 329.18% to $9.8 million in 2023, then surged by 90.62% to $18.6 million in 2024, then jumped by 59.12% to $29.6 million in 2025.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $29.6 million, $28.0 million, and $18.6 million for Q3 2025, Q1 2025, and Q3 2024 respectively.

Peer Comparison